Latest news
Innovent and Daiichi Sankyo sign deal for Vanflyta in China - Pharmaceutical Business review -Pharmaceutical Business review - · Mon, 10 Aug 2026 14:33:29 GMTInnovent Adds Vanflyta to China Oncology Portfolio - Contract PharmaContract Pharma · Mon, 10 Aug 2026 12:39:04 GMTInnovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 00:02:07 GMTOctapharma to Build $1.5B Manufacturing Site in South Carolina - Contract PharmaContract Pharma · Wed, 29 Jul 2026 07:00:00 GMT